This part of the site is strictly dedicated to healthcare professionals practicing in malarial endemic areas

MALARIA NEWS

Information and Training


Submit Advanced search
     


[08/11/2006]
 Democratic Republic of Congo
 < Back to the list 


Dr. Francis LOUIS, Yaoundé, Cameroon


> General country information | > Epidemiological facies | > Parasites | > Chemoresistance | > Vectors and the fight against vectors | > Management of malaria: | > Recommendations for travelers: | > Bibliographical references:

 General country information

- Area: 2,345,410 km2
- Population: 62,660,000 inhabitants (estimate dated June 2006)
- Official language: French
- Currency: Congolese Franc since June 17, 1998 (on January 6, 2005, 1 US dollar = CDF 417)
- Border countries: Angola (Cabinda), Congo, Central African Republic, Sudan, Rwanda, Burundi, Uganda, Tanzania, Zambia and Angola
- Capital: Kinshasa (3-6 million inhabitants)
- Main cities: Mbuji-Mayi, Matadi, Kisangani, Lubumbashi, Mbandaka, Kikwit, Gbadolite and Kolwezi.

                            

The country is largely composed of a central basin, drained by the Congo and its affluents.
In the Western part of the country, the topography (600 to 900 m) is composed of Mayombe and the Cristal Mountains. In the South, the Katanga plateaus reach an altitude of 1,500m, while the country’s highest summits are found in the East, in Kivu (Rwenzori Mountains, which reach 5,019m and the Virunga volcanic range, reaching over 3,000m).
In the basin, the DRC enjoys an equatorial climate that is always hot and humid. The climate turns tropical in the Northern part of the country and in the Southern part from the 5th parallel.
However, because of the vast surface area of this subcontinent, significant variations are observed, with a dry season that increases from the West to the East and from the North to the South (Fig. 2). When it exists, this dry season runs from May through August.

                      

Moyennes sur 30 ans (1961-1990) = Averages over 30 years (1961-1990)
Précipitations (mm) = Precipitation (mm)
Evapotranspiration (mm) = Evapotranspiration (mm)
Température moyenne = Average temperature
 Epidemiological facies
Malaria is omnipresent, except at altitudes over 1,800m (Fig. 3).
The following is observed :
- regions with constant transmission, with the population developing a high level of premunition (basin);
- regions with seasonal transmission, where the increase in clinical cases follows vectors’ seasonal peaks (Southern part of the country);
- epidemic regions, in the valleys of the mountainous regions (Kivu, Katanga).
Most of the country is hyperendemic (62), with average parasitological indices of 75% in children under 3 years old, 68% in 4-15 years old and 22% in adults (01). 
In Kivu, malaria is meso-endemic: the parasitological index is less than 30% in children under 5 years old and around 40% in older subjects (26). Malaria accounts for 12% of the causes of death. In the general population, malaria-related mortality is 3 per 1,000 annually. In 1-4 years old, it is 6 per 1,000 and in children under 12 months old, it is 18 per 1,000 (20). 
In the city of Kinshasa, huge differences in incidence and prevalence can be seen, depending on the geographic location (distance from the river and its affluents), level of urbanization (transmission is very low in the city center) and social standing of the residents of the different areas (22, 62). A study carried out by Mulumba et al. gives Kinshasa a parasitological index of 50% in children (22). Malaria is the leading cause for pediatric mortality (15% of deaths), far ahead of measles (6%) and gastroenteritis (3%) (19)
 Parasites
Plasmodium falciparum is the predominant malarial species. It is found, both alone and in combination, in 98% to 100% of parasitological diagnoses (03, 08, 37, 57).
Plasmodium malariae is the second most prevalent malarial species. It is found in 6% of the blood samples taken in Kinshasa (08) and in 32% of blood samples taken in Uvira, in South Kivu (08).
Plasmodium vivax is identified at a rate of 1.2% to 9% (03, 08) and Plasmodium ovale at a rate of 0.6% (08).
Three specific cases:
- in the Pygmies of the Eastern province, in the Eastern part of the DRC, Price et al. found Plasmodium falciparum and Plasmodium malariae at an equal frequency (04);
- in two 4 year-old twin sisters, Galeazzi et al. describe a triple infestation with Plasmodium falciparumPlasmodium malariae and Plasmodium ovale (56);
- Comellini et al. describe a case of congenital malaria with Plasmodium vivax (46).
 Chemoresistance

Resistance to chloroquine

According to Moran et al., resistance to chloroquine apparently appeared in the DRC in 1982, at the Eastern border, and, from there, it evidently spread throughout the entire country (22). Delacollette et al. confirm that in 1982, three Americans, members of the Peace Corps working in Kivu, contracted a chloroquine-resistant malaria (20).
Resistance is mentioned in 1985 by Ngimbi et al., in a study conducted in Kinshasa in 1984: out of 101 patients treated with chloroquine at a dose of 25 mg/kg given over three days, the rate of recovery was 95%. A strain was confirmed to be resistant in vitro (11). 
The same year, in an in vivo and in vitro study carried out in Kinshasa and Mbuji-Mayi, Phuc Nguyen-Dinh et al. did not observe any resistance (09). However, in 1986, they observed a level of resistance in vitro of 82% (13).
In vivo in 1988, Paluku et al. observed levels of sensitivity to chloroquine at a dose of 25 mg/kg over three days of 92% in children under 5 years old in Equador and of 44% only in Kinshasa (13). In 1989, the same authors observed sensitivity in vivo of 53.5 % in Kisangani, 19.5% in Bas-Congo and 55.5% in Bandundu (17).
In 1997, in vivo sensitivity to chloroquine at a dose of 25 mg/kg over three days was still 61%. It was 55% in 2003 (53); this inefficacy most likely explains that in Kinshasa and Kivu, regular treatment with chloroquine during pregnancy no longer prevents dysmaturity or low birth weight (54, 55).

Resistance to other antimalarial drugs

1. Amodiaquine:
No data published.

2. Quinine:
In 1989, in vivo sensitivity to quinine was 93.9% in Kisangani, 91.5% in Bas-Congo and 97.6% in Bandundu (17). 
Out of 34 children hospitalized with severe malaria and treated intravenously with quinine, fever clearance time was 44.1 hours and parasite clearance time was 59.6 hours (18).
In vitro, no plasmodium strain was found to be resistant to quinine (09).

3. Mefloquine:
No data published.

4. Halofantrine:
The study carried out by Mashako et al. in 1990 covered only 54 pediatric cases treated with halofantrine. Efficacy was 100%, fever clearance time was 18 hours and parasite clearance time was 37 hours (25).

5. The sulfadoxine-pyrimethamine combination:
In 1989, Paluku et al. observed an efficacy of the sulfadoxine-pyrimethamine combination in 95.8% of cases in Kisangani, 97.8% in Bas-Congo and 100% in Bandundu (17).
In 2003, Kazadi et al. noted 7.5% failures out of 333 treatments with the sulfadoxine-pyrimethamine combination for uncomplicated Plasmodium falciparum malaria (53).
 
6. Artemisinine derivatives:
No data published.

 Vectors and the fight against vectors

According to Karch et al., the anopheline fauna of Kinshasa comprises seven species: Anopheles gambiae is the species encountered most frequently (93.3%) and is responsible for one bite per person per night (b/p/night) in the city, against 26 in rural areas. The average annual inoculation rate is 197 infested bites per person per year (ib/p/year). Anopheles funestus, Anopheles paludis, Anopheles Hancocki, Anopheles coustani, Anopheles brunnipes and Anopheles nili are much more rare (29).
Coene has shown that in the city of Kinshasa, Culex mosquitoes are responsible for 121 b/p/night and Anopheles gambiae are responsible for 5.1 b/p/night. In rural areas, Anopheles gambiae is responsible for 13.3 b/p/night and Anopheles funestus is responsible for 2.4 b/p/night. The other species play a much smaller role: Anopheles nili (0.4 b/p/night), Anopheles brunnipes (0.7 b/p/night), Anopheles paludis (0.4 b/p/night) and Anopheles hancocki (0.2 b/p/night) (27).
In Bandundu, Karch and Mouchet have shown that Anopheles paludis is the most prevalent (55.1%), followed by Anopheles gambiae (27.8%), Anopheles funestus (11.2%), Anopheles moucheti (4.4%) and Anopheles nili (1.5%) (33).
According to Bafort, Anopheles marshalli apparently plays a role in malaria transmission in the Eastern part of the country (10).
Anopheles gambiae (68.3%), Culex (28.1 %) and Anopheles funestus (28.1 %) larvae have been isolated in the ponds of Kivu. Anopheline density is greater as the pond is shadier (59, 60).

In Kinshasa, using coils to fight mosquitoes inside homes has not proved effective: Coene et al. demonstrated that this practice was lowering the rate of bites by only 18% to 30% (16).
On the other hand, on the Bateke Plateaus near Kinshasa, the persistent use of insecticide-treated mosquito nets for beds has caused the number of Anopheles gambiae to drop by 94% and the number of ib/p/year to drop by 98% (37).

 Management of malaria:

Malaria is an especially difficult burden for the populations in the Democratic Republic of the Congo.
Accordingly, an annual average of nine febrile illnesses have been observed per person in children under 5 years old and four febrile illnesses per person in those over 5 years old. Fever-related mortality in children under 5 years old is 3 p. 1000 (Health for All Project, 1985).
Malaria infection is found in 37% of primigravida and in 24% of all pregnant women (13).
Meuris et al. have shown that 18% of pregnant women with a malaria infection give birth to  low birth-weight newborns (35). 

Families respond as best they can, spending approximately 25% of their income: 85.6% buy coils, 55.5% use aerosol insecticides and 38.6% have mosquito nets for beds (28). Forty-four percent of children receive presumptive treatment for malaria when they have a fever (36).

 Recommendations for travelers:

From 1952 to 1961, Belgium had an average of 35 cases of malaria imported from Zaire (former name of the Democratic Republic of the Congo) each year, with extremes of seven in 1958 and 79 in 1952 (05). From 1985 to 1995, the annual average was 289 cases, with extremes of 208 in 1985 and 423 in 1994 (50).

More recently, a study conducted concerning missionaries in the Northeastern part of the county showed that 62% of them were taking a chemical prophylaxis: either chloroquine alone (25.8%), chloroquine-proguanil combination (45.2%), chloroquine-pyrimethamine combination (3.2%), mefloquine alone (3.2%), pyrimethamine alone (3.2%), proguanil alone (19.4%), or pyrimethamine-dapsone combination (1.6%) (47).   

In its 2006 edition of health recommendations for travelers, the Institut français de veille sanitaire (French Health Watch Institute) classifies the Democratic Republic of the Congo in group three of “countries with a high prevalence of resistance to chloroquine or multiple resistance” (63). 
This means that the recommended chemical prophylaxis is:
- for adults: atovaquone-proguanil combination, mefloquine or doxycycline;
- for pregnant women: atovaquone-proguanil combination or mefloquine;
- for children: atovaquone-proguanil combination, mefloquine or doxycycline, at doses suitable for their weight (weight-related dose).
Of course, simple measures of individual protection against anopheline bites are to be remembered: skin repellants and persistent insecticide-treated mosquito nets for beds. 
Prophylaxis for malaria is no longer needed in the mountainous regions of the country (Kivu) above 1,800 meters.
In the rest of the country, chemical prophylaxis is not necessary for short stays of less than seven days, if mosquito-protection rules are followed carefully and if you are able, during the months following return to a malaria-free area, to visit a doctor immediately in the event of a fever, informing him or her of your travels to a malaria-stricken area.

 Bibliographical references:

01 – Duren AN – essai d’étude sur l’importance du paludisme dans la mortalité au Congo belge – Ann. Soc. belge Med. Trop. 1951 ; 31 : 129-47.
02 – Chardome M, Janssen PJ – Enquête sur l’incidence malarienne par la méthode dermique dans la région de Lubilash (Congo Belge). Ann. Soc. belge Med. Trop. 1952 ; 32 : 209-11.
03 – Van der Berghe L, Chardome M, Peel E – Traitement antimalarien suppressif par la chloroquine chez des enfants en milieu coutumier au Congo Belge. Ann. Soc. belge Med. Trop. 1952 ; 32 : 571-8.
04 – Price DL, Mann GV, Roels OA, Merrill JM – Parasitism in Congo Pygmies. Am. J. Trop. Med. Hyg. 1963; 12: 383-7.
05 – Limbos P – La pathologie tropicale d’importation en Belgique. Bull. Soc. Path. Exot. 1964 ; 57 : 767-81.
06 – Motulsky AG, Vandepitte J, Fraser GR – Population genetic studies in the Congo. I. Glucose-6-Phosphate Deshydrogenase Deficiency, Hemoglobin S, and Malaria. Am. J. Human Gen. 1966; 18: 514-37.
07 – Buck AA, Anderson RI, MacRae AA, Fain A – Epidemiology of polyparasitism. I. Occurrence, Frequency and Distribution of Multiple Infections in rural Communities in Chad, Peru, Afghanistan, and Zaire. Tropenmed. Parasit. 1978; 29: 61-70.
08 – Ngimbi NP, Beckers A, Wéry M – Aperçu de la situation épidémiologique du paludisme à Kinshasa (République du Zaïre) en 1980. Ann. Soc. belge Med. Trop. 1982 ; 62 : 121-37.
09 – Phuc Nguyen-Dinh, Schwartz IK, Sexton JD, Bomboto Egumb, Botomwito Bolange, Kalisa Ruti, Ngimbi NP, Wéry M – In vivo and in vitro susceptibility to chloroquine of Plasmodium falciparum in Kinshasa and Mbuji-Mayi, Zaire. Bull. World Health Organ. 1985 ; 63 : 325-30.
10 – Bafort JM – Anopheles marshalli s.l., a secondary vector of malaria in Africa. Trans. R. Soc. Trop. Med. Hyg. 1985; 79: 566-7.
11 – Ngimbi NP, Wéry M, Henry MC, Mulumba PC – Reponse in vivo à la chloroquine au cours du traitement du paludisme à Plasmodium falciparum en région suburbaine de Kinshasa, Zaïre. Ann. Soc. belge Med. Trop. 1985 ; 65 suppl. 2 : 123-35.
12 – Gerniers MM, Lamboray JL – Le paludisme dans la population de Kinshasa : perception du problème, moyens d’action, évaluation. Ann. Soc. belge Med. Trop. 1985 ; 65 suppl. 2 : 215-22.
13 – Paluku KM, Breman JG, Moore M, Ngimbi NP, Sexton JD, Roy J, Steketee RW, Weinmann JM, Kalisa-Ruti, Mambu ma-Disu H – Response of children with Plasmodium falciparum to chloroquine and development of a national malaria treatment policy in Zaire. Trans. R. Soc. Trop. Med. Hyg. 1988; 82: 353-7.
14 – Steketee RW, Breman JG – Malaria infection in pregnant women in Zaire : the effects and the potential for intervention. Ann. Trop. Med. Parasitol. 1988; 82: 113-20. 
15 – Kalenga MK, Mutach K, Nsungula K, Odimba FK, Kabyla I – Les anémies au cours de la grossesse. Etude clinique et biologique. A propos de 463 cas observés à Lubumbashi (zaïre). Rev. Fr. Gynecol. Obstet. 1989 ; 84 : 393-9.
16 – Coene J, Ngimbi NP, Mulumba MP, Wéry M – Ineffectiveness of mosquito coils in Kinshasa, Zaire.  Trans. R. Soc. Trop. Med. Hyg. 1989; 83: 568-9.
17 – Paluku KM, Ngimbi NP, Mushiya Wa Kalonji, Mambu Ma Disu H  – Efficacité comparative des traitements alternatifs dans les infections à Plasmodium falciparum au Zaïre. Ann. Soc. belge Med. Trop. 1989 ; 69 : 25-33.
18 –  AE, Phuc Nguyen-Dinh, Davachi F, Yemvula B, Malanda S, Nzeza M, Williams SB, De Zwart JF, Nzeza M – Intravenous quinine therapy of hospitalized children with Plasmodium falciparum malaria in Kinshasa, Zaire. Am. J. Trop. Med. Hyg. 1989 ; 40 : 360-4.
19 – Greenberg AE, Ntumbanzondo M, Ntula N, Mawa L, Howell J, Davachi F – Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull. World Health Organ. 1989 ; 67 : 189-96.
20 – Delacollette C, Van der Stuyft P, Molima K, Delacollette-Lebrun C, Wéry M – Etude de la mortalité globale et de la mortalité liée au paludisme dans le Kivu montagneux, Zaïre. Rev. Epidemiol. Santé Publ. 1989 ; 37 : 161-6.
21 – Moran JS, Bernard KW – The spread of chloroquine-resistant malaria in Africa. JAMA 1989; 262: 245-8.
22 – Mulumba MP, Wéry M, Ngimbi NN, Paluku K, Van der Stuyft P, De Muynk A – Le paludisme de l’enfant à Kinshasa (Zaïre). Influence des saisons, de l’âge, de l’environnement et du standing familial. Med. Trop. 1990 ; 50 : 53-64.
23 – Colebunders R, Bahwe Y, Nekwei W, Ryder R, Perriens J, Nsimba K, Turner A, Francis H, Lebughe I, Van der Stuyft P, Piot P – Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. J. Inf. 1990; 21: 167-73.
24 – Omanga U, Kapepela K – Epidémiologie du paludisme congénital en milieu urbain de Kinshasa (Zaïre). Ann. Pediatr. 1990 ; 37 : 195-7.
25 – Mashako MNL, Kingway MP, Kayembe N – Traitement par le chlorhydrate d’halofantrine du paludisme à Plasmodium falciparum dans une zone de résistance. Analyse de 54 cas pédiatriques. Ann. Soc. belge Med. trop. 1990 ; 70 : 25-32.
26 – Delacollette C, Van der Stuyft P, Molima K, Hendrix L, Wéry M – Indices paludométriques selon l’âge et selon les saisons dans la zone de santé de Katana, au Kivu montagneux, Zaïre. Ann. Soc. belge Med. trop. 1990 ; 70 : 263-8.
27 – Coene J – Prospects for malaria control in urban and rural Kinshasa. Ann. Soc. belge Med. trop. 1991 ; 71 Suppl. 1 : 103-12.
28 – Zandu A, Malengreau M, Wéry M – Pratiques et dépenses pour la protection contre les moustiques dans les ménages à Kinshasa, Zaïre. Ann. Soc. belge Med. trop. 1991 ; 71 : 259-66.
29 – Karch S, Asidi N, Manzambi ZM, Salaun JJ – La faune anophélienne et la transmission du paludisme humain à Kinshasa (Zaïre). Bull. Soc. Path. Exot. 1992 ; 85 : 304-9.
30 – Delacollette C, Van der Stuyft P, Molima K, Delacollette-Lebrun C, Wéry M – Demographic findings relevant for health care planning and evaluation collected through a malaria control project in the Kivu Mountains, Zaire. Acta Trop. 1992; 52: 189-99.
31 – Karch S, Asidi N, Manzambi ZM, Salaun JJ – Efficacy of Bacillus sphaericus against the malaria vector Anopheles gambiae and other mosquitoes in swamps and rice fields in Zaire. J. Am. Mosq. Control Ass. 1992; 8: 376-80.
32 – Garin B, Salaun JJ, Peyron F, Vigier JP, Busangu J, Perrone J – Rapid in vivo detection of chloroquine resistance by the quantitative buffy coat malaria diagnosis system. Am. J. trop. Med. Hyg. 1992 ; 47 : 446-9.
33 – Karch S, Mouchet J – Anopheles paludis, vecteur important du paludisme au Zaïre. Bull. Soc. Path. Exot. 1992 ; 85 : 388-9.
34 – Nyirjesy P, Kavasya T, Axelrod P, Fischer PR – Malaria during pregnancy : neonatal morbidity and mortality and the efficacy of chloroquine prophylaxis. Clin. Infect. Dis. 1993 ; 16 : 127-32.
35 – Meuris S, Bokumu Bosongo Piko, EErens P, Vanbellinghen AM, Dramaix M, Hennart P – Gestational malaria : assessment of its consequences on fetal growth. Am. J. Trop. Med. Hyg. 1993 ; 48 : 603-9.
36 – Vernon AA, Taylor WR, Biey A, Mundeke KM, Chahnazarian A, Habicht H, Mutombo M, Bakutuvwidi Makani – Changes in use of health services in a rural health zone in Zaire. Int. J. Epidemiol. 1993 ; 22 : S20-S31.
37 – Karch S, Garin B, Asidi N, Manzambi Z, Salaun JJ, Mouchet J – Moustiquaires imprégnées contre le paludisme au Zaïre. Ann. Soc. belge Med. trop. 1993 ; 73 : 37-53.
38 – Hedberg K, Shaffer N, Davachi F, Hightower A, Lyamba B, Paluku KM, Phuc Nguyen-Dinh, Breman JG – Plasmodium falciparum-associated anemia in children at a large urban hospital in Zaire. Am. J. Trop. Med. Hyg. 1993 ; 48 : 365-71. 
39 – Boivin MJ, Giordani B, Ndanga K, Maky MM, Manzeki KM, Ngunu N, Muamba K – Effects of treatment for intestinal parasites and malaria on the cognitive abilities of schoolchildren in Zaire, Africa. Health Psychol. 1993; 12: 220-6.
40 – Coene J – Malaria in urban and rural Kinshasa: the entomological input. Med. Vet. Entomol. 1993 ; 7 : 127-37.
41 – Mulumba PM, Wéry M, Ngimbi NN, Paluku KM, De Muynk A, Van der Stuyft P – Relation entre parasitémie à Plasmodium et accès fébrile dans différents groupes de population à Kinshasa, Zaïre. Ann. Soc. belge Med. trop. 1994 ; 74 : 275-89.
42 – Tshefu K, James MA – falciparum antigen (Pf70) and protection against malaria in a human population living under intense transmission in Kinshasa, Zaire. Trop. Med. Parasitol. 1995 ; 46 : 72-6.
43 – Delacollette C, Taelman H, Wéry M – An etiologic study of hemoglobinuria and blackwater fever  in the Kivu mountains, Zaire. Ann. Soc. belge Med. trop. 1995 ; 75 : 51-63.
44 – Tshikuka JG, Scott ME, Gray-Donald K, Kalumba ON – Multiple infection with Plasmodium and helminths in communities of low and relatively high socio-economic status. Ann. Trop. Med. Parasitol. 1996 ; 90 : 277-93.
45 – Rey JL, Cavallo JD, Milleliri JM, L’Hoest S, Soares JL, Piny N, Coué JC, Jouan A – Les fièvres d’origine indéterminée (FOI) dans les camps de réfugiés rwandais de la region de Goma au Zaïre (septembre 1994). Bull. Soc. Path. Exot. 1996 ; 89 : 204-8.
46 – Comellini L, Tozzola A, Baldi F, Brusa S, Serra L, Agostini C, Scaglia M – Plasmodium vivax congenital malaria in a newborn of a Zairian immigrant. Ann. Trop. Paediatr. 1998; 18 : 41-3.
47 – Burdon J – Use of malarial prophylaxis amongst a population of expatriate church workers in Northeast Zaire. J. Travel Med. 1998; 5: 36-8.
48 – Pelloux H – Voyages hors de nos frontières : des parasitoses à ne pas méconnaître. Rev. Med. Suisse Romande 1999 ; 119 : 93-7.
49 – Tona L, Ngimbi NP, Tsakala M, Mesia K, Cimanga K, Apers S, De Bruyne T, Pieters L, Totté J, Vlietinck AJ – Antimalarial activity of 20 crude extracts from nine medicinal plants used in Kinshasa, Congo. J. Ethnopharmacol. 1999 ; 68 : 193-203.
50 – Muentener P, Schlagenhauf P, Steffen R – Le paludisme importé (1985 – 1995) : tendances et perspectives. Bull. WHO 1999 ;  77 : 560-6.
51 – Kalenga MK, Nyembo MK, Nshimba M, Foidard JM – Etude de l’anémie chez les femmes enceintes et les femmes allaitantes de Lubumbashi (République Démocratique du Congo). J. Gynecol. Obstet. Biol. Reprod. 2003 ; 32 : 347-53.
52 – Kalenga MK, Nyembo MK, Nshimba M, Foidard JM – Anémie associée au paludisme et aux helminthiases intestinales à Lubumbashi. Santé Publique 2003 ; 15 : 413-21. 
53 – Kazadi WM, Vong S, Makina BN, Mantshumba JC, Kabuya W, Kebela BI, Ngimbi NP – Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo. Trop. Med. Int. Health 2003 ; 8 : 868-875.
54 – Mulumba PM, Kabongo MJM, Woto EE – La prévention de l’hypotrophie foetale échappe désormais à la chloroquino-prophylaxie dans l’environnement de Kinshasa. Med. Trop. 2003 ; 63 : 168-70.
55 – Mugisho E, Dramaix M, Porignon D, Mouafo JB, Venbellingem AM, Hennart P, Meuris S – Ineffectiveness of chloroquine antenatal prophylaxis in East of Democratic Republic of Congo (RDC). Trop. Doctor 2003 ; 33 : 177-8.
56 – Galeazzi G, Ardoin F, Petithory JC, Laurent C – Triple infestation plasmodiale chez deux sœurs jumelles originaires de la République Démocratique du Congo. Bull. Soc. Path. Exot. 2003 ; 96 : 96-8.
57 – Breman JG, Alilio MS, Mills A – Conquering the intolerable burden of malaria : what’s new, what’s needed. A summary. Am. J. Trop. Med. Hyg. 2004 ; 71 suppl. 2 : 1-15.
58 – Kazadi W, Sexton JD, Makengo Bigonsa, Bompela W’Okanga, Way M – Malaria in primary school children and infants in Kinshasa, Democratic Republic of the Congo : surveys from the 1980s and 2000. Am. J. Trop. Med. Hyg. 2004 ; 71 suppl. 2 : 97-102.
59 – Byamungu N, Baluku B – Influence de la configuration des gîtes sur la densité des larves de moustiques à Lwiro, Sud-Kivu, République Démocratique du Congo. Med. Trop. 2004 ; 64 : 99-101.
60 – Byamungu N, Baluku B – Effet de l’ombrage sur la reproduction des moustiques dans les canaux d’évacuation à Lwiro, Sud-Kivu, République Démocratique du Congo. Med. Trop. 2004 ; 64 : 101-2.
61 – Tona L, Cimanga RK, Mesia K, Musuamba CT, De Bruyne T, Apers S, Hernans N, Van Miert S, Pieters L, Totté J, Vlietinck AJ – In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J. Ethnopharmacol. 2004 ; 93 : 27-32.
62 – Mouchet J, Carnevale P, Coosemans M, Julvez J, Manguin S, Richard-Lenoble D, Sircoulon J – Biodiversité du paludisme dans le monde. John Libbey Eurotext éd., Montrouge, France 2004, 124-6.
63 – Institut de veille sanitaire – Recommandations sanitaires pour les voyageurs 2006 (à l’intention des professionnels de santé). BEH 2006, n° 23-24, 154-63.

 

© Copyright sanofi-aventis 2002-2008 all rights reserved
Disease information about malaria:the parasite, the symptoms, prevention and treatment options, atlas of malaria, etc.